{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:54:20Z","timestamp":1648763660702},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,6,26]],"date-time":"2013-06-26T00:00:00Z","timestamp":1372204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00063-013-0262-y","type":"journal-article","created":{"date-parts":[[2013,6,24]],"date-time":"2013-06-24T06:56:19Z","timestamp":1372056979000},"page":"138-144","source":"Crossref","is-referenced-by-count":1,"title":["Leberfunktionsst\u00f6rungen in der Intensivmedizin \u2013 Konsequenzen f\u00fcr die Therapie invasiver Candidainfektionen"],"prefix":"10.1007","volume":"110","author":[{"given":"A.E.","family":"Canbay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gl\u00f6ckner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,26]]},"reference":[{"key":"262_CR1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00134-005-0023-3","volume":"32","author":"Brienza","year":"2006","unstructured":"Brienza N, Dalfino L, Cinnella G et al (2006) Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med 32:267\u2013274","journal-title":"Intensive Care Med"},{"key":"262_CR2","first-page":"1516","volume":"52","author":"Canbay","year":"2005","unstructured":"Canbay A, Chen SY, Gieseler RK et al (2005) Overweight patients are more susceptible for acute liver failure. Hepatogastroenterol 52:1516\u20131520","journal-title":"Hepatogastroenterol"},{"key":"262_CR3","first-page":"714","volume":"108","author":"Canbay","year":"2011","unstructured":"Canbay A, Tacke F, Hadem J et al (2011) Acute liver failure: a life-threatening disease. Dtsch \u00c4rztebl Int 108:714\u2013720","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"262_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","volume":"18","author":"Cornely","year":"2012","unstructured":"Cornely OA, Bassetti M, Calandra T et al (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl 7):19\u201337","journal-title":"Clin Microbiol Infect"},{"key":"262_CR5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","volume":"18","author":"Cuenca-Estrella","year":"2012","unstructured":"Cuenca-Estrella M, Verweij PE, Arendrup MC et al (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 18(Suppl 7):9\u201318","journal-title":"Clin Microbiol Infect"},{"key":"262_CR6","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1128\/AAC.01279-08","volume":"53","author":"Damle","year":"2009","unstructured":"Damle BD, Dowell JA, Walsky RL et al (2009) In vitro and in vivo studies to characterize the clearance mechanism and potential cytochrome P450 interactions of anidulafungin. Antimicrob Agents Chemother 53:1149\u20131156","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR7","unstructured":"Davis S, Kouza A, Wiegand T, Vazquez J (2008) Conversion of intravenous echinocandins to oral azoles for invasive candidiasis: impact on outcomes and resource utilisation. European Congress on Clinical Microbiology and Infectious Diseases (ECCMID 2008); Abstract O458"},{"key":"262_CR8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/0091270004265644","volume":"44","author":"Dowell","year":"2004","unstructured":"Dowell JA, Knebel W, Ludden T, Stogniew M et al (2004) Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal. J Clin Pharmacol 44:590\u2013598","journal-title":"J Clin Pharmacol"},{"key":"262_CR9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1177\/0091270005281234","volume":"45","author":"Dowell","year":"2005","unstructured":"Dowell JA, Schranz J, Baruch A, Foster G (2005) Safety and pharmacokinetics of coadministered voriconazole and anidulafungin. J Clin Pharmacol 45:1373\u20131382","journal-title":"J Clin Pharmacol"},{"key":"262_CR10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0091270006297227","volume":"47","author":"Dowell","year":"2007","unstructured":"Dowell JA, Stogniew M, Krause D et al (2007) Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment. J Clin Pharmacol 47:461\u2013470","journal-title":"J Clin Pharmacol"},{"key":"262_CR11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0091270006296764","volume":"47","author":"Dowell","year":"2007","unstructured":"Dowell JA, Stogniew M, Krause D et al (2007) Lack of pharmacokinetic interaction between anidulafungin and tacrolimus. J Clin Pharmacol 47:305\u2013314","journal-title":"J Clin Pharmacol"},{"key":"262_CR12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0091270004270146","volume":"45","author":"Dowell","year":"2005","unstructured":"Dowell JA, Stogniew M, Krause D et al (2005) Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine. J Clin Pharmacol 45:227\u2013233","journal-title":"J Clin Pharmacol"},{"key":"262_CR13","unstructured":"Fachinformation Anidulafungin (Ecalta\u00ae); Pfizer Pharma GmbH; Juli 2011"},{"key":"262_CR14","unstructured":"Fachinformation Fluconazol (Diflucan\u00ae); Pfizer Pharma GmbH; M\u00e4rz 2012"},{"key":"262_CR15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10096-006-0159-2","volume":"25","author":"Falagas","year":"2006","unstructured":"Falagas ME, Apostolou KE, Pappas VD et al (2006) Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis 25:419\u2013425","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"262_CR16","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00134-009-1508-2","volume":"35","author":"Fuhrmann","year":"2009","unstructured":"Fuhrmann V, Kneidinger N, Herkner H et al (2009) Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 35:1397\u20131405","journal-title":"Intensive Care Med"},{"key":"262_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","volume":"43","author":"Garey","year":"2006","unstructured":"Garey KW, Rege M, Pai MP et al (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43:25\u201331","journal-title":"Clin Infect Dis"},{"key":"262_CR18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ncpgasthep0602","volume":"3","author":"Geier","year":"2006","unstructured":"Geier A, Fickert P, Trauner M (2006) Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 3:574\u2013585","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"262_CR19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/AAC.01078-10","volume":"55","author":"Gorski","year":"2011","unstructured":"Gorski E, Esterly JS, Postelnick M et al (2011) Evaluation of hepatotoxicity with off-label oral-treatment doses of voriconazole for invasive fungal infections. Antimicrob Agents Chemother 55:184\u2013189","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1055\/s-2003-39650","volume":"41","author":"Gr\u00fcnhage","year":"2003","unstructured":"Gr\u00fcnhage F, Fischer HP, Sauerbruch T et al (2003) Drug- and toxin-induced hepatotoxicity. Z Gastroenterol 41:565\u2013578","journal-title":"Z Gastroenterol"},{"key":"262_CR21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.md.0000101573.54295.bd","volume":"82","author":"Henrion","year":"2003","unstructured":"Henrion J, Schapira M, Luwaert R et al (2003) Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine 82:392\u2013406","journal-title":"Medicine"},{"key":"262_CR22","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0924-8579(08)70008-6","volume":"32","author":"Kett","year":"2008","unstructured":"Kett DH, Cubillos GF (2008) Anidulafungin in the treatment of patients with invasive candidiasis. Int J Antimicrob Agents 32(Suppl 2):S99\u2013S102","journal-title":"Int J Antimicrob Agents"},{"key":"262_CR23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/01.CCM.0000259462.97164.A0","volume":"35","author":"Kramer","year":"2007","unstructured":"Kramer L, Jordan B, Druml W et al (2007) Incidence and prognosis of early hepatic dysfunction in critically ill patients \u2013 a prospective multicenter study. Crit Care Med 35:1099\u20131104","journal-title":"Crit Care Med"},{"key":"262_CR24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1440-1746.2011.06807.x","volume":"27","author":"Ku\u010dera","year":"2012","unstructured":"Ku\u010dera O, Rou\u0161ar T, Sta\u0148kov\u00e1 P et al (2012) Susceptibility of rat non-alcoholic fatty liver to the acute toxic effect of acetaminophen. J Gastroenterol Hepatol 27:323\u2013330","journal-title":"J Gastroenterol Hepatol"},{"key":"262_CR25","unstructured":"Kumar A, Skrobik I, Guzman J et al (2007) The high mortality of Candida septic shock is explained by excessive delays in initiation of antifungal therapy. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2007) Abstract K-2174"},{"key":"262_CR26","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/ALN.0b013e318266c6df","volume":"117","author":"Lescot","year":"2012","unstructured":"Lescot T, Karvellas C, Beaussier M et al (2012) Acquired liver injury in the intensive care unit. Anesthesiology 117:898\u2013904","journal-title":"Anesthesiology"},{"key":"262_CR27","unstructured":"Meyer E, Schwab F, Geffers C, Gastmeier P (2010) Primary candidemia in 523 intensive care units. European Congress on Clinical Microbiology and Infectious Diseases (ECCMID 2010); Abstract O405"},{"key":"262_CR28","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","volume":"49","author":"Morrell","year":"2005","unstructured":"Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640\u20133645","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","volume":"354","author":"Navarro","year":"2006","unstructured":"Navarro VJ, Senior JR (2006) Drug-related hepatotoxicity. N Engl J Med 354:731\u2013739","journal-title":"N Engl J Med"},{"key":"262_CR30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","volume":"48","author":"Pappas","year":"2009","unstructured":"Pappas PG, Kauffman CA, Andes D et al (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503\u2013535","journal-title":"Clin Infect Dis"},{"key":"262_CR31","doi-asserted-by":"crossref","unstructured":"Penndorf V, Saner F, Gerken G, Canbay A (2012) Leberparameter in der Intensivmedizin. Zentralbl Chir [online Vorabver\u00f6ffentlichung]","DOI":"10.1055\/s-0031-1271601"},{"key":"262_CR32","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","volume":"356","author":"Reboli","year":"2007","unstructured":"Reboli AC, Rotstein C, Pappas PG et al (2007) Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356:2472\u20132482","journal-title":"N Engl J Med"},{"key":"262_CR33","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2165\/11584810-000000000-00000","volume":"29","author":"Reboli","year":"2011","unstructured":"Reboli AC, Rotstein C, Kett DH et al (2011) Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients. Pharmacoeconomics 29:705\u2013717","journal-title":"Pharmacoeconomics"},{"key":"262_CR34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1469-0691.2012.03784.x","volume":"18","author":"Ruhnke","year":"2012","unstructured":"Ruhnke M, Paiva JA, Meersseman W et al (2012) Anidulafungin for the treatment of candidaemia\/invasive candidiasis in selected critically ill patients. Clin Microbiol Infect 18:680\u2013687","journal-title":"Clin Microbiol Infect"},{"key":"262_CR35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1439-0507.2011.02040.x","volume":"54","author":"Ruhnke","year":"2011","unstructured":"Ruhnke M, Rickerts V, Cornely OA et al (2011) Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses 54:279\u2013310","journal-title":"Mycoses"},{"key":"262_CR36","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.21593","volume":"45","author":"Savransky","year":"2007","unstructured":"Savransky V, Nanayakkara A, Vivero A et al (2007) Chronic intermittent hypoxia predisposes to liver injury. Hepatology 45:1007\u20131013","journal-title":"Hepatology"},{"key":"262_CR37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-8278(88)80514-2","volume":"7","author":"Boekhorst","year":"1988","unstructured":"Boekhorst T te, Urlus M, Doesburg W et al (1988) Etiologic factors ofjaundice in severely ill patients. A retrospective study in patients admitted to an intensive care unit with severe trauma or with septic intra-abdominal complications following surgery and without evidence of bile duct obstruction. J Hepatol 7:111\u2013117","journal-title":"J Hepatol"},{"key":"262_CR38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1211","volume":"15","author":"Temple","year":"2006","unstructured":"Temple R (2006) Hy\u2019s law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf 15:241\u2013243","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"262_CR39","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00134-009-1511-7","volume":"35","author":"Thomson","year":"2009","unstructured":"Thomson SJ, Cowan ML, Johnston I (2009) \u201eLiver function tests\u201c on the intensive care unit: a prospective, observational study. Intensive Care Med 35:1406\u20131411","journal-title":"Intensive Care Med"},{"key":"262_CR40","unstructured":"Verma A, Auzinger G, Kantecki M et al (2012) Clinical experience with anidulafungin for treatment of invasive fungal infections in patients with liver dysfunction and high incidence of multi organ failure \u2013 a single centre observational study. European Congress on Clinical Microbiology and Infectious Diseases (ECCMID 2012); Abstract O117"},{"key":"262_CR41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1432-2277.2011.01376.x","volume":"25","author":"Wree","year":"2012","unstructured":"Wree A, Bechmann LP, Kumarasamy N et al (2012) Elevated gamma-glutamyltransferase is associated with mortality in lung transplantation for cystic fibrosis. Transpl Int 25:78\u201386","journal-title":"Transpl Int"},{"key":"262_CR42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000322298","volume":"84","author":"Wree","year":"2011","unstructured":"Wree A, Dech\u00eane A, Herzer K et al (2011) Steroid and ursodesoxycholic acid combination therapy in severe drug-induced liver injury. Digestion 84:54\u201359","journal-title":"Digestion"},{"key":"262_CR43","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/thx.2009.113464","volume":"64","author":"Zhai","year":"2009","unstructured":"Zhai R, Sheu CC, Su L et al (2009) Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis. Thorax 64:784\u2013790","journal-title":"Thorax"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-013-0262-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-013-0262-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-013-0262-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:29:00Z","timestamp":1558578540000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-013-0262-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,26]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1007\/s00063-013-0262-y","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,26]]}}}